June 15, 2024

TF Supplements Recalls RHINO Products for Undeclared Drugs

TF Supplements of Teas is voluntarily recalling RHINO 7 dietary supplements because they contain desmethyl carbondenafil and dapoxetine, two drugs that are not declared on the label. No reports of adverse events or illnesses have been received to date in connection with the consumption of this product.

Dismethyl carbondenafil may post a threat because this PDE-5 inhibitor may interact with nitrates found in some prescription drugs and can lower blood pressure to life-threatening levels. Dapoxetine has not been approved for human use by the FDA and its safety has not been established. It belongs to a class of drugs used to treat depression. These drugs can increase the risk of suicidal thinking and behavior in children, adolescents, and young adults.

This product, RHINO 7, is packaged in a bottle containing six capsules with lot number K824B719-P, and in a single (1) count capsule hang card with lot number SU-5102617*RP at the consumer level. Lot numbers are found on the back top right of the 1 count card and on the side of the 6 count bottle.

If you purchased this product, do not use it. Discard in a sealed container or return to the place of purchase for a full refund. If you have experienced problems after taking this supplement, you can report it to the FDA’s MedWatch Adverse Event Reporting program.

Rhino 7 Supplement Recall

RHINO 7 Dietary Supplement Recall

Report Your Food Poisoning Case

Error: Contact form not found.


Home About Site Map Contact Us Sponsored by Pritzker Hageman, P.A., a Minneapolis, MN law firm that helps food poisoning victims nationally.